Trial Profile
Clinical Trials Insight: 700050064
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 07 Apr 2010
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Decreased libido
- Focus Registrational; Therapeutic Use
- Sponsors VIVUS
- 07 Apr 2010 Company associated changed from VIVUS to Acrux.
- 20 Oct 2009 New trial record.